Owing to this dual mechanism of action, GLP-1 RAs have become the cornerstone of management of type 2 diabetes mellitus (T2DM), particularly in people with inadequate glycaemic control despite standard therapies [2]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.